Updates are available Correction dated 2024-10-21
Click to view Correction: https://doi.org/10.1038/s41586-024-07928-6
-
Authors
Shilts, Jarrod https://orcid.org/0000-0002-0959-0583
Severin, Yannik https://orcid.org/0000-0003-4482-6237
Galaway, Francis
Müller-Sienerth, Nicole https://orcid.org/0000-0002-7527-5127
Chong, Zheng-Shan
Pritchard, Sophie
Teichmann, Sarah https://orcid.org/0000-0002-6294-6366
Vento-Tormo, Roser https://orcid.org/0000-0002-9870-8474
Snijder, Berend https://orcid.org/0000-0003-3386-6583
Wright, Gavin J.
- License Information
-
More Information
Article History
Received: 30 June 2021
Accepted: 28 June 2022
First Online: 3 August 2022
Change Date: 21 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-024-07928-6
Competing interests
: S.T. has received remuneration in the last three years for consulting and membership of scientific advisory boards from Foresite Labs, GlaxoSmithKline, Biogen, Qiagen and Transition Bio, and is an equity holder of Transition Bio. The remaining authors declare no competing interests.
